Expanded Admission Screening Protocol for Candida Auris Beneficial

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 8, 2024 -- Health care facilities should consider initiating or expanding admission screening for Candida auris based on community prevalence rates, according to a study published online Oct. 31 in the American Journal of Infection Control.

Aaron Cheng, M.P.H., from Mount Sinai Beth Israel in New York City, and colleagues examined the utility of expanding a C. auris admission screening protocol at an acute care hospital to screen all patients presenting from any skilled nursing facility. The analysis included 591 patients screened on admission for C. auris from January 2022 through September 2023.

According to the researchers, 14 cases were identified (2.4 percent), including nine cases presenting with tracheostomies or ventilator dependence, and were classified as high-risk. At the time of screening, five cases were considered low-risk. Under the prior criteria, eight of the newly identified cases would not have been screened.

"Our study supports the need for hospitals to adopt expanded screening protocols to enhance infection control practices," coauthor Scott Lorin, M.D., of Mount Sinai Brooklyn and Icahn Mount Sinai, said in a statement. "Broader screening not only identifies cases early, but also allows for targeted precautions, reducing the risk of hospital-based outbreaks. The implementation of proactive protocols, based on community prevalence rates, can be a key tool in controlling the spread of this emerging global health threat."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-10 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords